BURGESS DANIEL D
SEC insider (Form 3/4/5 filer). CIK 0001239650. Director at Cidara Therapeutics, Inc. (CDTX). 3 reported Form 4/5 transactions since Sep 2024; latest on Jan 7, 2026. Located in SAN DIEGO, CA.
Companies BURGESS DANIEL D has filed insider reports for
- Cidara Therapeutics, Inc. (CDTX): Director
BURGESS DANIEL D
CIK: 0001239650
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (66.7%)
Compensation grants
Other (G, F, J, C, D, …)1 (33.3%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
CDTX
Cidara Therapeutics, Inc.
Director
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- Jan 7, 2026CDTX
Cidara Therapeutics, Inc.
DispositionIndirect150 shares at avg. $221.50$33K - Jun 18, 2025CDTX
Cidara Therapeutics, Inc.
AwardDirectStock Option (right to buy)
11.1K shares- - Dec 17, 2024CDTX
Cidara Therapeutics, Inc.
AwardDirectStock Option (right to buy)
20.5K shares-
1-3 of 3 transactions